Trial Profile
A phase I trial of Bevacizumab biosimilar RPH-001 in cancer.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Cancer
- Focus Adverse reactions
- 25 Jul 2017 New trial record